Screener
Artiva Biotherapeutics, Inc. ARTV Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
FAQ
- What is Artiva Biotherapeutics, Inc.'s accrued expenses?
- Artiva Biotherapeutics, Inc. (ARTV) reported accrued expenses of $4.64M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s accrued expenses changed year-over-year?
- Artiva Biotherapeutics, Inc.'s accrued expenses increased by 27.2% year-over-year, from $3.65M to $4.64M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s accrued expenses?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s accrued expenses has grown at a -2.8% compound annual growth rate (CAGR), from $8.02M to $7.57M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Artiva Biotherapeutics, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude